Skip to main navigation Skip to search Skip to main content

Safety of dipyridamole testing in patients with cerebrovascular disease

  • Jean Lette
  • , Giancarlo Carini
  • , James L. Tatum
  • , Nancy Paquet
  • , Guy Bisson
  • , Michel Picard
  • , Hee Seung Bom
  • , Anna Maria Lusa
  • , Graziana Labanti
  • , Jeanne Teitelbaum
  • , Jean Verreault
  • , Michel Cerino
  • , Daniel McNamara
  • , Marie Claire Eybalin
  • , Andre Levasseur
  • , François Langlais
  • , D. Douglas Miller

Research output: Contribution to journalArticlepeer-review

Abstract

Severe undiagnosed coronary artery disease is a major cause of morbidity and mortality in patients with carotid stenoses.22,23 Our study demonstrates that dipyridamole testing carries a very low risk of neurologic complications in patients with cerebrovascular disease.

Original languageEnglish (US)
Pages (from-to)535-537
Number of pages3
JournalThe American Journal of Cardiology
Volume75
Issue number7
DOIs
StatePublished - Mar 1 1995
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Safety of dipyridamole testing in patients with cerebrovascular disease'. Together they form a unique fingerprint.

Cite this